Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the
C
ardio‐
O
ncology
S
tudy
G
roup of the
H
eart
F
ailure
A
ssociation of the
E
uropean
S
ociety of
C
ardiology in collaboration with the
I
nternational
C
ardio‐
O
ncology
S
ociety
2020 ◽
Vol 22
(11)
◽
pp. 1945-1960
◽
2019 ◽
Vol 32
(6)
◽
pp. 540-559
◽
2017 ◽
Vol 228
◽
pp. 52-57
◽